This Month, Triple Your Impact
This Month, Triple Your Impact
Make 3x the difference during Alzheimer’s & Brain Awareness Month with our 3x Bonus Match Challenge — but only until midnight June 16. Your gift can go three times as far to help provide care and support and advance research.
Donate NowNIH Director Affirms to Congress His Commitment to Advancing Progress on Alzheimer’s
— Remarks come during 2025 AIM Advocacy Forum —
Washington, D.C., June 10, 2025 — National Institutes of Health (NIH) Director Dr. Jay Bhattacharya affirmed his commitment to advancing progress in the fight against Alzheimer’s disease and other dementia during a Senate budget hearing Tuesday.“I am fully committed to making progress, scientific progress, on Alzheimer’s. I know all too well from my own research work, and from friends and family members, the devastating toll of this disease,” said Bhattacharya.
His remarks came before a room filled with Alzheimer’s Association and Alzheimer’s Impact Movement (AIM) advocates attending the hearing, which was held during the 2025 Alzheimer’s Impact Movement Advocacy Forum.
“On behalf of Americans impacted by dementia, we appreciate Director Bhattacharya acknowledging our advocates in attendance at today’s hearing and for his testimony,” said Joanne Pike, DrPH, president and CEO of the Alzheimer’s Association. “The Alzheimer’s Association is looking forward to working with him and Congress to accelerate — not stop — decades of progress on this devastating disease.”
Tuesday’s was the latest hearing of the Senate Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittee, where bipartisan support for sustained federal investment in Alzheimer’s and dementia research was on full display.
“We are immensely grateful to our bipartisan congressional champions for their steadfast commitment to advancing Alzheimer’s research, which has and will continue to make a meaningful impact in the lives of Americans,” continued Pike.
Lawmakers from both parties shared their personal experiences with Alzheimer’s and thanked our advocates for their dedication. Perhaps most importantly for the research community, multiple members asked Dr. Bhattacharya about pauses and delays in grant funding being issued, including for Alzheimer’s Disease Research Centers (ADRC) across the nation. Members also raised concerns about proposed cuts at the NIH and reaffirmed their commitment to the Alzheimer’s and dementia community.
About the Alzheimer's Association
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.
Alzheimer’s Impact Movement
The Alzheimer's Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer's Association. AIM works to develop and advance policies to overcome Alzheimer's disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.